Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease

Abstract

Transplantation of stem cells into the brain attenuates functional deficits in the central nervous system via cell replacement, the release of specific neurotransmitters, and the production of neurotrophic factors. To identify patient‐specific and safe stem cells for treating Alzheimer's disease (AD), we generated induced pluripotent stem cells (iPSCs) derived from mouse skin fibroblasts by treating protein extracts of embryonic stem cells. These reprogrammed cells were pluripotent but nontumorigenic. Here, we report that protein‐iPSCs differentiated into glial cells and decreased plaque depositions in the 5XFAD transgenic AD mouse model. We also found that transplanted protein‐iPSCs mitigated the cognitive dysfunction observed in these mice. Proteomic analysis revealed that oligodendrocyte‐related genes were upregulated in brains injected with protein‐iPSCs, providing new insights into the potential function of protein‐iPSCs. Taken together, our data indicate that protein‐iPSCs might be a promising therapeutic approach for AD. Stem Cells Translational Medicine 2017;6:293–305

Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model

“…Spontaneous alternation in Y-maze is a behavioural test for short-term spatial learning and memory 13. Contextual fear-conditioning is a test for long-term spatial learning and memory function 14. Open-field test is commonly used to assess anxiety-like behaviours in rodents 15…”

A Comparison of Lysosomal Enzymes Expression Levels in Peripheral Blood of Mild- and Severe-Alzheimer’s Disease and MCI Patients: Implications for Regenerative Medicine Approaches

“…In the last decade, effort has been made to explore innovative regenerative medicine approaches for AD. This includes: replacement cell therapy approaches by implantation of different types of stem cells in AD animal models [ 7 ]; production of neuronal devise with innovative nanomaterials for improving or delay neurologic impairment [ 8 ]; new drug delivery approaches such as the use of an efficient monoclonal antibody against the amyloid-β peptide [ 9 ]. In the meantime, new potential diagnostic tools are also being explored [ 10 , 11 , 12 ].…”

Alzheimer's Disease: A Special Collection

“…Cha et al report that treatment with iPSCs generated via the exposure of mouse skin fibroblasts to protein extracts of embryonic stem cells may also represent a relevant therapeutic option for AD . In this study, from Inhee Mook‐Jung and Hyo‐Soo Kim (Seoul National University Hospital, Republic of Korea), the authors demonstrate that iPSCs transplanted into a mouse AD model differentiate into glial cells, reduce plaque depositions, and mitigate observed cognitive dysfunction.…”